Kymera Therapeutics KYMR
NASDAQ KYMR
$107.39 -2.73 (-2.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kymera Therapeutics (KYMR) Long-Term Investments (2020 - 2026)

Updated

Kymera Therapeutics' Long-Term Investments came in at $813.9 million for Q2 2026, up 173.5% from $297.63 million a year earlier but down 9.0% from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Long-Term Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Kymera Therapeutics' Long-Term Investments was $771.2 million, up 112.9% from FY2024.

  • Long-Term Investments carries a five-year compound annual growth rate of 36.5% (FY2020 to FY2025).
  • Going back by year, Long-Term Investments was $362.2 million in FY2024 (+489.6%), $61.43 million in FY2023 (-59.7%), $152.33 million in FY2022 (+21.7%) and $125.2 million in FY2021 (-23.0%).
  • The five-year range for quarterly Long-Term Investments is $61.4 million (Q1 2023) to $894.72 million (Q1 2026).
  • Year-over-year, Long-Term Investments has increased for ten consecutive quarters, with growth averaging 182.0% over the last eight quarters.
  • The fastest year-over-year change in Long-Term Investments over five years came in Q4 2024 (growth of 489.6%), and the weakest in Q3 2021 (a decline of 60.2%).
  • Business Quant data shows KYMR's Long-Term Investments at $894.72 million (Q1 2026), $771.2 million (Q4 2025) and $473.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 266.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 2.62 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.56 Bn
10 Kymera Therapeutics 9.12 Bn 6.42 Bn - 813.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 813.90 Mn
Mar 31, 2026 894.72 Mn
Dec 31, 2025 771.20 Mn
Sep 30, 2025 473.10 Mn
Jun 30, 2025 297.63 Mn
Mar 31, 2025 312.34 Mn
Dec 31, 2024 362.20 Mn
Sep 30, 2024 361.04 Mn
Jun 30, 2024 192.45 Mn
Mar 31, 2024 224.40 Mn
Dec 31, 2023 61.43 Mn
Sep 30, 2023 77.00 Mn
Jun 30, 2023 104.80 Mn
Mar 31, 2023 61.40 Mn
Dec 31, 2022 152.33 Mn
Sep 30, 2022 113.70 Mn
Jun 30, 2022 90.20 Mn
Mar 31, 2022 102.50 Mn
Dec 31, 2021 125.20 Mn
Sep 30, 2021 74.70 Mn
API Access

Kymera Therapeutics Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=KYMR&period=max&api_key=YOUR_API_KEY